Skip to main content

Table 2 Linear regression analysis to compare cardiac markers between the sevoflurane and propofol groups (n = 102)

From: Late pharmacologic conditioning with volatile anesthetics after cardiac surgery

Cardiac marker (U/L)

Unadjusted difference in means

(point estimate)

95% Cl

Adjusted difference in means

(point estimate)

95% CI

Troponin T, 4 hours (μg/L)

-0.3

-0.7, 0.1

-0.1

-0.2, 0.1

CK, 4 hours (U/L)

-140 a

-250, -30

-38

-96, 20

CK-MB, 4 hours (U/L)

-2.4

-23.9, 19.2

1.2

-6.4, 8.7

Myoglobin, 4 hours (μg/L)

-113 a

-187, -39

-42

-100, 16

Troponin T, POD1 (μg/L)

-0.4 a

-0.7, -0.1

-0.2 a

-0.4, -0.02

CK, POD1 (U/L)

-258 a

-434, -83

-169 a

-331, -8

CK-MB, POD1 (U/L)

-4.6

-27.5, 18.3

-1.1

-13.2, 11.0

Myoglobin, POD1 (μg/L)

-107

-217, 3

-48

-157, 60

  1. The model is adjusted for age, blood products, baseline value of corresponding cardiac injury marker on ICU admission, and extracorporeal circulation (ECC) time. The propofol group is the reference. aP < 0.05, statistically significant.
  2. 4 hours, 4 hours after ICU admission; CK, creatine kinase; CK-MB, creatine kinase, heart muscle tissue; POD1, first postoperative day.